Clinical Trial Update: Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate cetuximab with radiation therapy for stage III non-small cell lung cancer. The study is completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-17